Effects of Ericksonian Hypnotherapy on Anxiety
Neurophysiological and Psychological Effects of Ericksonian Hypnotherapy on Generalized Anxiety Disorder: An EEG-Based Clinical Study
NA · Uskudar University · NCT06811311
This study is testing whether Ericksonian hypnotherapy can help people with Generalized Anxiety Disorder feel less anxious and change their brain activity.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Uskudar University (other) |
| Locations | 1 site (Istanbul) |
| Trial ID | NCT06811311 on ClinicalTrials.gov |
What this trial studies
This study investigates the neurophysiological and psychological effects of Ericksonian hypnotherapy in individuals diagnosed with Generalized Anxiety Disorder (GAD) using electroencephalography (EEG). A total of 60 participants will be recruited from psychiatric clinics in Istanbul and randomly assigned to either receive 12 sessions of hypnotherapy or no intervention. The study aims to assess changes in brain activity and anxiety symptoms before and after treatment, utilizing various psychological assessments and EEG measurements to evaluate outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18-65 diagnosed with Generalized Anxiety Disorder who are not currently receiving other forms of treatment.
Not a fit: Patients with comorbid psychiatric disorders or those currently on medications affecting EEG activity may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a novel therapeutic approach for managing anxiety symptoms in patients with GAD.
How similar studies have performed: While the use of hypnotherapy in treating anxiety is established, this specific approach using EEG to measure neurophysiological changes is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of Generalized Anxiety Disorder (GAD) based on DSM-5 criteria * Aged 18-65 years * Capable of providing written informed consent * Fluent in Turkish (for hypnosis and assessments) * Not currently receiving psychotherapy or pharmacological treatment for anxiety Exclusion Criteria: * Presence of comorbid psychiatric disorders (e.g., schizophrenia, bipolar disorder, major depression requiring immediate intervention) * History of neurological conditions (e.g., epilepsy, traumatic brain injury, stroke) * Current use of medications affecting EEG activity (e.g., benzodiazepines, SSRIs, antipsychotics) * Previous experience with hypnotherapy (to avoid expectancy bias) * Substance abuse or dependence within the last six months * Pregnancy or breastfeeding * Severe medical conditions that may interfere with participation
Where this trial is running
Istanbul
- Üsküdar University, Neuro-Psychology Lab — Istanbul, Turkey (Türkiye) (RECRUITING)
Study contacts
- Principal investigator: Selami Varol Ülker, Phd — Üsküdar University
- Study coordinator: Selami Varol Ülker, Phd
- Email: selamivarol.ulker@uskudar.edu.tr
- Phone: +90536-436-09-41
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Generalized Anxiety Disorder, Anxiety Disorders, Psychophysiological Disorders, Stress-Related Disorders, Ericksonian Hypnotherapy, Hypnosis and Anxiety, EEG Neurophysiology, Anxiety Treatment